Show simple item record

Competition between Generic and Branded Drugs

dc.contributor.author Grabowski, Henry G
dc.contributor.editor Hsieh, C-R
dc.contributor.editor Sloan, Frank A
dc.date.accessioned 2013-05-15T22:25:38Z
dc.date.issued 2007-04-30
dc.identifier.isbn 0521874904
dc.identifier.isbn 9780521874908
dc.identifier.uri https://hdl.handle.net/10161/7370
dc.description.abstract The pharmaceutical industry worldwide is a rapidly burgeoning industry contributing to growth of gross domestic product and employment. Technological change in this field has been very rapid, with many new products being introduced. For this reason in part, health care budgets throughout the world have increased dramatically, eliciting growing pressures for cost containment. This book explores four important issues in pharmaceutical innovations: (1) the industry structure of pharmaceutical innovation; (2) incentives for correcting market failures in allocating resources for research and development; (3) competition and marketing; and (4) public evaluation of the benefits and costs of innovation. The lessons are applicable to countries all over the world, at all levels of economic development. By discussing existing evidence this book proposes incentive arrangements to accomplish social objectives.
dc.publisher Cambridge University Press
dc.relation.ispartof Pharmaceutical innovation: incentives, competition, and cost-benefit analysis in international perspective
dc.subject Business & Economics
dc.title Competition between Generic and Branded Drugs
dc.type Book section
pubs.begin-page 153
pubs.end-page 288
pubs.organisational-group Duke
pubs.organisational-group Economics
pubs.organisational-group Trinity College of Arts & Sciences
pubs.place-of-publication Cambridge; New York


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record